Anne Le Selected Research

Anne Le Research Topics

Disease

54	Neoplasms (Cancer) 02/2024 - 11/2009
7	Carcinogenesis 02/2024 - 11/2009
6	Frailty 03/2024 - 01/2020
6	Breast Neoplasms (Breast Cancer) 02/2024 - 12/2011
6	Hypoxia (Hypoxemia) 01/2023 - 11/2009
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 08/2012
5	Inflammation (Inflammations) 03/2024 - 01/2020
5	Lymphoma (Lymphomas) 11/2021 - 02/2010
2	Pulmonary Arterial Hypertension 01/2024 - 11/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 09/2023 - 09/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2023 - 09/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2018
1	renal Oncocytoma 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 02/2024
1	Atopic Dermatitis (Atopic Eczema) 01/2024
1	Pulmonary Hypertension 01/2023
1	Hyperkalemia 12/2022
1	Hypotension (Low Blood Pressure) 12/2022
1	Fatigue 12/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2022
1	Glomerulonephritis 03/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Hyperglycemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Barth Syndrome 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021

Drug/Important Bio-Agent (IBA)

18	Glutamine (L-Glutamine)FDA Link 11/2022 - 11/2009
13	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2009
11	Lactic Acid (Lactate)FDA LinkGeneric 11/2021 - 11/2009
9	GlutaminaseIBA 01/2021 - 01/2012
8	EnzymesIBA 09/2023 - 06/2012
8	Glutamic Acid (Glutamate)FDA Link 12/2022 - 06/2015
5	LipidsIBA 02/2024 - 03/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2014
4	isospaglumic acid (NAAGA)IBA 12/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2015
3	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2020
3	IsotopesIBA 11/2021 - 01/2012
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 01/2018
3	Oxygen (Dioxygen)IBA 01/2021 - 11/2009
3	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 01/2021 - 01/2019
3	Lactate Dehydrogenase 5IBA 08/2015 - 02/2010
2	NAD (NADH)IBA 04/2024 - 02/2010
2	KynurenineIBA 03/2024 - 01/2020
2	CalciumIBA 03/2024 - 11/2019
2	Triglycerides (Triacylglycerol)IBA 02/2024 - 11/2022
2	CytokinesIBA 01/2024 - 01/2021
2	Amino Acids FDA Link 01/2023 - 01/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2022 - 01/2019
2	GlycogenIBA 11/2022 - 01/2016
2	gamma-Aminobutyric Acid (GABA)IBA 11/2021 - 01/2021
2	Ketone BodiesIBA 01/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 11/2019
2	CB-839IBA 10/2020 - 05/2016
2	Transcription Factors (Transcription Factor)IBA 06/2012 - 11/2009
2	p38 Mitogen-Activated Protein KinasesIBA 01/2009 - 10/2008
1	Tryptophan (L-Tryptophan)FDA Link 04/2024
1	Diacylglycerol O-AcyltransferaseIBA 02/2024
1	Immunoglobulin A (IgA)IBA 01/2024
1	long-chain-fatty-acid-CoA ligaseIBA 09/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2023
1	Dinoprostone (PGE2)FDA Link 04/2023
1	HexosaminesIBA 01/2023
1	Uridine Diphosphate (UDP)IBA 01/2023
1	Uridine Diphosphate N-AcetylglucosamineIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Losartan (Cozaar)FDA LinkGeneric 12/2022
1	2- butyl- 4- chloro- 1- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- 1H- imidazole- 5- carboxaldehydeIBA 12/2022
1	PPAR gammaIBA 12/2022
1	losartan carboxylic acidIBA 12/2022
1	Antihypertensive Agents (Antihypertensives)IBA 12/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2022
1	Phosphocreatine (Neoton)IBA 11/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2022
1	HydrogelsIBA 11/2021
1	Valsartan (Vals)FDA Link 11/2021
1	CarbonIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	Succinic Acid (Succinate)IBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Drug CombinationsIBA 01/2021
1	Cardiolipins (Cardiolipin)IBA 01/2021
1	AcidsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	PresenilinsIBA 01/2021
1	Chelating AgentsIBA 01/2021
1	CopperIBA 01/2021
1	AntioxidantsIBA 10/2020
1	PlatinumIBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020

Therapy/Procedure

36	Therapeutics 02/2024 - 01/2009
5	Drug Therapy (Chemotherapy) 02/2024 - 01/2018
3	Radiotherapy 01/2023 - 01/2018
1	Immunotherapy 01/2021